May 4, 2020 / 12:12 PM / 21 days ago

BRIEF-Eagle Pharma Advances Novel And Proprietary Formulation Of Fulvestrant Product Candidate Ea-114

May 4 (Reuters) - Eagle Pharmaceuticals Inc:

* EAGLE PHARMACEUTICALS ADVANCES NOVEL AND PROPRIETARY FORMULATION OF FULVESTRANT PRODUCT CANDIDATE EA-114; COMPANY TO REQUEST ADDITIONAL MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below